Nanomedicine Therapies Current Events | Nanomedicine Therapies News | 3
|
| Page
3 of
10 |
195 Results |
|
|
|
Sort By:
Page Views | Date |
Cancer cells suppress large regions of DNA by a reversible process that can be tackled
Cancer researchers at Sydney's Garvan Institute, in collaboration with Spanish scientists, have formulated a new concept for how cancer cells can escape normal growth controls, which may have far-reaching implications for the new generation of cancer therapies. view more (2006-04-24)
Newfound roadblock to interferon effectiveness against malignant melanoma
Researchers have uncovered a significant contributing factor to interferon resistance of malignant melanoma cells. view more (2005-09-22)
With a flash of light, a neuron's function is revealed
There's a new way to explore biology's secrets. With a flash of light, scientists from the U.S. Department of Energy's Lawrence Berkeley National Laboratory and the University of California, Berkeley zeroed in on the type of neural cell that controls swimming in larval zebrafish. view more (2009-09-17)
Targeting lung cancer
As reported in the June 1 issue of G&D, Drs. Katerina Politi, Harold Varmus and colleagues at the Memorial Sloan Kettering Cancer Center in New York have developed a novel animal model of lung adenocarcinoma that will be of great use in testing the efficacy of targeted therapies against human lung cancer. view more (2006-05-18)
Commentary highlights impact of food-cancer drug interactions
A commentary in the Journal of Clinical Oncology (JCO) urges researchers to explore an intriguing approach to reduce the dose, and therefore the cost, of oral targeted cancer therapies. view more (2007-07-18)
UT Southwestern researchers refocus studies on patients with HIV, hepatitis
As HIV patients live longer thanks to advanced therapies, researchers are looking for better ways to treat accompanying maladies such as hepatitis that traditionally were not emphasized. view more (2006-10-12)
Study shows chemotherapy improves survival among older breast cancer patients
The average age of a woman diagnosed with breast cancer is 63, so it is critical to have effective proven, therapies for an older patient population. view more (2009-05-14)
MU scientists convert pigs' connective tissue cells into stem cells
For years, proponents have touted the benefits of embryonic stem cell research, but the potential therapies still face hurdles. view more (2009-06-26)
Certain combination therapy found more effective for treating malaria in African children
Ugandan children who received the combination therapy of artemether-lumefantrine experienced a lower rate of treatment failure compared to other combination therapies, according to a study in the May 23/30 issue of JAMA, a theme issue on malaria. view more (2007-05-23)
Research provides promising evidence of new drug therapies in lethal lung disease
Several promising new treatments may prolong lives as well as improve the quality of life for people living with pulmonary arterial hypertension. view more (2006-04-07)
There goes the neighborhood: Vascular niche nurtures brain tumor stem cells
Self-renewing cancer stem cells (CSCs) comprise only a tiny fraction of most brain tumors, but eliminating them is likely to have a profound impact on the ability of a tumor to survive and grow. view more (2007-01-17)
Treatment advances for lymphoma have reduced deaths by 70%
New treatment advances for patients with follicular lymphoma, previously considered an incurable cancer, have reduced deaths in the first four years by 70 percent. view more (2005-10-21)
Personalized treatment for early lung cancer
Cancer vaccines and targeted therapies are beginning to offer new treatment options following surgery for patients with early stages of lung cancer, experts said at the first European Multidisciplinary Conference in Thoracic Oncology (EMCTO) in Lugano, Switzerland (1-3 May 2009). view more (2009-05-04)
Substance in tree bark could lead to new lung-cancer treatment
Researchers at UT Southwestern Medical Center have determined how a substance derived from the bark of the South American lapacho tree kills certain kinds of cancer cells, findings that also suggest a novel treatment for the most common type of lung cancer. view more (2007-06-26)
Pittsburgh scientists find protein may be key to new therapies for elevated triglycerides
Diabetes researchers at the John G. Rangos Sr. Research Center at Children's Hospital of Pittsburgh of UPMC have identified a potential target for the development of new therapies to treat hypertriglyceridemia, a lipid disorder commonly seen in people who are obese and diabetic. view more (2008-05-27)
Modeling head and neck cancers
In a report to be published in the May 15th issue of G&D, Dr. Xiao-Jing Wang and colleagues at Oregon Health & Science University present a novel model of head and neck cancer, which is expected to become an invaluable tool in the evaluation of biomarkers and therapies to treat this devastating disease. view more (2006-05-15)
New centre launched to investigate link between human sugars and disease
A multidisciplinary centre launched today will promote a far broader understanding of the role sugars play in human disease, scientists say. view more (2005-04-28)
U-M researchers ID gene involved in pancreatic cancer
Researchers from the University of Michigan Comprehensive Cancer Center have identified a gene that is overexpressed in 90 percent of pancreatic cancers, the most deadly type of cancer. view more (2009-03-03)
Tocilizumab study offers new hope for children with arthritis
A new study has confirmed significant improvements after treatment with tocilizumab amongst children with systemic juvenile idiopathic arthritis (sJIA), who do not tolerate or have an inadequate response to conventional therapies. view more (2006-06-23)
Study shows cancer vaccines led to long-term survival for patients with metastatic melanoma
Hoag Memorial Hospital Presbyterian today announced promising data from a clinical study showing patient-specific cancer vaccines derived from patients' own cancer cells and immune cells were well tolerated and resulted in impressive long-term survival rates in patients with metastatic melanoma whose disease had been minimized by other therapies. view more (2009-07-29)
|
|
| Page
3 of
10 |
195 Results |
|
|
|
Sort By:
Page Views | Date |
|
